To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal ...
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results